Your browser doesn't support javascript.
loading
Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels-A pilot study in healthy individuals with implications for COVID-19 and ARDS.
Buder, Felix; Selejan, Simina-Ramona; Hohl, Mathias; Kindermann, Michael; Herr, Christian; Lepper, Philipp M; Bals, Robert; Salzberger, Bernd; Mahfoud, Felix; Böhm, Michael.
Afiliação
  • Buder F; Department of Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Selejan SR; Department of Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Hohl M; Department of Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Kindermann M; Department of Internal Medicine, Cardiology and Intensive Care Medicine, Caritas Hospital St. Theresia Saarbrücken, Saarbrücken, Germany.
  • Herr C; Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Lepper PM; Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Bals R; Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
  • Salzberger B; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus, Saarbrücken, Germany.
  • Mahfoud F; Department for Infection Control and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.
  • Böhm M; Department of Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, University Hospital, Saarland University, Homburg, Saar, Germany.
PLoS One ; 17(10): e0275181, 2022.
Article em En | MEDLINE | ID: mdl-36251689

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Proteína HMGB1 / Tratamento Farmacológico da COVID-19 / Glycyrrhiza Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Proteína HMGB1 / Tratamento Farmacológico da COVID-19 / Glycyrrhiza Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha